Dallas’ Spark Biomedical has closed a $15 million Series A funding round led by Waco-based WAVE Ventures and New York-based Pathway to Cures.
The investment will support Spark Biomedical’s core business focus on neurological health, hemostasis, and women’s health and also help advance the company’s ongoing development of its bioelectronic treatments.
“We envision a world where personalized and accessible healthcare transforms lives through the power of bioelectronic medicine,” reads a description of the company on Spark’s website.
Spark, founded in 2018, focuses on developing wearable neurostimulation solutions that can offer alternative treatments to traditional therapies for issues like opioid addiction. These devices can precisely target and stimulate vagus and trigeminal nerves, prompting the central nervous system to “modulate pathways, reduce discomfort, and support physiological balance, resulting in non-invasive, drug-free support for a range of conditions,” said Spark in an April 30 press release.
Ultimately, Spark aims to deliver “targeted relief—without invasive procedures or pharmaceuticals.”
Spark Biomedical CEO and Co-founder Daniel Powell called the Series A funding a “pivotal moment” for the company.
“This investment empowers us to advance the development of non-invasive neurostimulation therapies that address significant unmet clinical needs. Our vision is to redefine how neurological conditions are treated — not with chemicals, but with precisely targeted bioelectric solutions,” said Powell.
Spark’s wearable technology could also help in novel areas, like reducing spatial disorientation and motion sickness among U.S. Air Force pilots. Earlier in the year, the company obtained a $480,000 grant from the Defense Health Agency to explore the tech’s effectiveness in a study led by the Air Force’s 59th Medical Wing out of Joint Base San Antonio.
Allen Page, Managing Partner at WAVE Ventures, said they are proud of the newly announced partnership with Spark.
“From behavioral health to women’s health, Spark will address some of the world’s most challenging medical conditions and greatly improve people’s lives,” she said in the press release.